possible increased risk of cleft lip and palate in babies exposed to Lamictal during pregnancy

November 2006

The FDA is warning about a possible increased risk of cleft lip and palate in babies exposed to Lamictal during pregnancy.

This is due to a recent report from the North American Antiepileptic Drug (NAAED) Pregnancy Registry.

But the risk seems low...an increase from 0.05% to 0.3% in general to 0.9% in babies exposed to Lamictal (lamotrigine).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote